Dismountable Protein Corona‐Modified Virus‐Like Manganese‐Arsenic Nanomedicine Enables Safe and Targeted Delivery for Synergistic Arsenotherapy
Advanced Materials · 2024
DOI: 10.1002/adma.202408361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Haina Tian und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, 271016, China. Hauptthemen laut MEDLINE: Manganese, Arsenic, Nanomedicine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation, Taishan Scholars Program of Shandong Province.
Abstract (Originalsprache)
Arsenic agents have shown great potential in fighting leukemia, but are poorly known in treating solid tumors, mainly ascribing to the rapid clearance and low targeting ability. It is reported that morphology modulation can enhance the interaction between nanoparticles and cell membrane. Herein, a dismountable protein corona‐modified virus‐like manganese‐arsenic nanomedicine (vMnAs@HR) is rationally proposed for realizing safe and targeted delivery and synergistic arsenotherapy. The virus‐like manganese‐arsenic nanoparticle (vMnAs) is constructed followed by modification of a temporary R848‐loaded HDL (HR) protein corona. Upon intravenous injection, the HR protein corona is stable and actively targeted to tumor tissue by taking advantage of the interaction between HDL and its receptor SR‐BI. Intriguingly, upon accumulated in the tumor, HR can be jettisoned and interacted with macrophages for proinflammatory phenotype modulation. The re‐exposed vMnAs can efficiently enhance endocytosis by taking advantage of the rationally designed spiky morphology. Moreover, the released double‐stranded DNA (dsDNA) and manganese ions during tumor cell apoptosis can cooperatively activate cyclic guanosine monophosphate adenosine monophosphate synthase (cGAS)‐stimulator of interferon genes (STING) signaling pathway of DCs for systematic immune activation. It is anticipated that this morphology‐transformable nanomedicine can realize safe and efficient arsenic delivery for synergistic arsenotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, 271016, China.
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.
- Key Laboratory of Biopharmaceutical Preparation and Delivery, Chinese Academy of Sciences, Beijing, 100190, China.
- School of Radiology, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, 271016, China.
ORCID-Profile: Haina Tian, Changlong Wang
Förderung
- National Natural Science Foundation of China
- Shandong Provincial Natural Science Foundation
- Taishan Scholars Program of Shandong Province
- Youth Innovation Team Program of Colleges and Universities in Shandong Province
- Talent Introduction Project of Shandong First Medical University
- Medicine and Health Science & Technology Project of Shandong Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Tian, H., Gao, X., Wei, H., Ding, Z., Ming, Q., Wu, W., Zhang, X., Ren, S., Li, Z., Shao, F., & Wang, C. (2024). Dismountable Protein Corona‐Modified Virus‐Like Manganese‐Arsenic Nanomedicine Enables Safe and Targeted Delivery for Synergistic Arsenotherapy. Advanced Materials. https://doi.org/10.1002/adma.202408361
Vancouver
Tian H, Gao X, Wei H, Ding Z, Ming Q, Wu W, et al. Dismountable Protein Corona‐Modified Virus‐Like Manganese‐Arsenic Nanomedicine Enables Safe and Targeted Delivery for Synergistic Arsenotherapy. Advanced Materials. 2024. doi:10.1002/adma.202408361
BibTeX
@article{Tian2024,
author = {Tian, Haina and Gao, Xiaoyang and Wei, Haiyun and Ding, Zongyao and Ming, Qian and Wu, Weiwei and Zhang, Xiao and Ren, Shuaiwei and Li, Zhaowei and Shao, Fengying and Wang, Changlong},
title = {Dismountable Protein Corona‐Modified Virus‐Like Manganese‐Arsenic Nanomedicine Enables Safe and Targeted Delivery for Synergistic Arsenotherapy},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202408361}
}
EUVIMED